Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

AI-powered ECG assessments may improve heart transplant rejection warnings

20 October 2026 · By · Wire by Fusion42

Published

20 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at cardiovascularbusiness.com →

◆ Verified

Fusion42 · 20 October 2026 · Fusion42 review

NYU Langone Health researchers developed an AI model combining ECG and blood biomarkers to detect heart transplant rejection non-invasively, outperforming current blood test methods by reducing false positives and potentially sparing patients from biopsies.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 7 Oct 2026 and 20 Oct 2026.

◆ ◆ The Wire takeaway

You can cut patient risk and costs by replacing invasive biopsy with AI-powered ECG analysis in heart transplants. This opens a path to earlier rejection detection and faster treatment decisions in transplant centres.

◆ Coverage

2 sources · first reported 7 Oct 2026 · latest 20 Oct 2026

◆ Related on Wire

◆ Topics

Medtechai-ecgheart-transplantnon-invasive-diagnosticsfalse-positive-reduction